Tissue engineering approaches for lymphedema: biomaterial innovations and clinical potential
The lymphatic system plays a critical role in maintaining fluid balance and immune regulation. Lymphedema, and other lymphatic disorders, highlight the need for advanced therapeutic approaches, including tissue engineering. This review examines the latest developments in artificial lymphatic tissue...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Cell and Developmental Biology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2025.1537050/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849731419532689408 |
|---|---|
| author | Pooja Deshpande Maya Dornbrand-Lo Varoon Phondge Patrick Kelly Alex K. Wong |
| author_facet | Pooja Deshpande Maya Dornbrand-Lo Varoon Phondge Patrick Kelly Alex K. Wong |
| author_sort | Pooja Deshpande |
| collection | DOAJ |
| description | The lymphatic system plays a critical role in maintaining fluid balance and immune regulation. Lymphedema, and other lymphatic disorders, highlight the need for advanced therapeutic approaches, including tissue engineering. This review examines the latest developments in artificial lymphatic tissue engineering, focusing on scaffold materials, lymphangiogenic factors, and regenerative strategies to replicate the intricacy of lymphatic vessels and nodes. We conducted a thorough literature review of current practices and applications in lymphatic tissue engineering. Findings show that biomaterials such as hydrogels, decellularized matrices, and synthetic polymers provide effective scaffolds for lymphatic endothelial cell proliferation and lymphangiogenesis. Advances in growth factor delivery and stem-cell based therapies have further enhanced the viability of engineered lymphatic tissues. Despite promising progress, challenges in achieving functional replication of lymphatic structures and clinical translation of research remain. Ongoing research must address scaffold biocompatibility, optimized growth factor targeting, and scalable production to advance therapeutic options for lymphatic disorders. This review underscores the potential for transformative patient outcomes through innovative bioengineering solutions. |
| format | Article |
| id | doaj-art-dafc8b0a205c47f38bcc9381a243e725 |
| institution | DOAJ |
| issn | 2296-634X |
| language | English |
| publishDate | 2025-04-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Cell and Developmental Biology |
| spelling | doaj-art-dafc8b0a205c47f38bcc9381a243e7252025-08-20T03:08:33ZengFrontiers Media S.A.Frontiers in Cell and Developmental Biology2296-634X2025-04-011310.3389/fcell.2025.15370501537050Tissue engineering approaches for lymphedema: biomaterial innovations and clinical potentialPooja DeshpandeMaya Dornbrand-LoVaroon PhondgePatrick KellyAlex K. WongThe lymphatic system plays a critical role in maintaining fluid balance and immune regulation. Lymphedema, and other lymphatic disorders, highlight the need for advanced therapeutic approaches, including tissue engineering. This review examines the latest developments in artificial lymphatic tissue engineering, focusing on scaffold materials, lymphangiogenic factors, and regenerative strategies to replicate the intricacy of lymphatic vessels and nodes. We conducted a thorough literature review of current practices and applications in lymphatic tissue engineering. Findings show that biomaterials such as hydrogels, decellularized matrices, and synthetic polymers provide effective scaffolds for lymphatic endothelial cell proliferation and lymphangiogenesis. Advances in growth factor delivery and stem-cell based therapies have further enhanced the viability of engineered lymphatic tissues. Despite promising progress, challenges in achieving functional replication of lymphatic structures and clinical translation of research remain. Ongoing research must address scaffold biocompatibility, optimized growth factor targeting, and scalable production to advance therapeutic options for lymphatic disorders. This review underscores the potential for transformative patient outcomes through innovative bioengineering solutions.https://www.frontiersin.org/articles/10.3389/fcell.2025.1537050/fulllymphedemalymphaticstissue engineeringbioengineeringbiomaterials |
| spellingShingle | Pooja Deshpande Maya Dornbrand-Lo Varoon Phondge Patrick Kelly Alex K. Wong Tissue engineering approaches for lymphedema: biomaterial innovations and clinical potential Frontiers in Cell and Developmental Biology lymphedema lymphatics tissue engineering bioengineering biomaterials |
| title | Tissue engineering approaches for lymphedema: biomaterial innovations and clinical potential |
| title_full | Tissue engineering approaches for lymphedema: biomaterial innovations and clinical potential |
| title_fullStr | Tissue engineering approaches for lymphedema: biomaterial innovations and clinical potential |
| title_full_unstemmed | Tissue engineering approaches for lymphedema: biomaterial innovations and clinical potential |
| title_short | Tissue engineering approaches for lymphedema: biomaterial innovations and clinical potential |
| title_sort | tissue engineering approaches for lymphedema biomaterial innovations and clinical potential |
| topic | lymphedema lymphatics tissue engineering bioengineering biomaterials |
| url | https://www.frontiersin.org/articles/10.3389/fcell.2025.1537050/full |
| work_keys_str_mv | AT poojadeshpande tissueengineeringapproachesforlymphedemabiomaterialinnovationsandclinicalpotential AT mayadornbrandlo tissueengineeringapproachesforlymphedemabiomaterialinnovationsandclinicalpotential AT varoonphondge tissueengineeringapproachesforlymphedemabiomaterialinnovationsandclinicalpotential AT patrickkelly tissueengineeringapproachesforlymphedemabiomaterialinnovationsandclinicalpotential AT alexkwong tissueengineeringapproachesforlymphedemabiomaterialinnovationsandclinicalpotential |